Cargando…

Mass Spectrometric-Based Proteomics for Biomarker Discovery in Osteosarcoma: Current Status and Future Direction

Due to a lack of novel therapies and biomarkers, the clinical outcomes of osteosarcoma patients have not significantly improved for decades. The advancement of mass spectrometry (MS), peptide quantification, and downstream pathway analysis enables the investigation of protein profiles across a wide...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sirikaew, Nutnicha, Pruksakorn, Dumnoensun, Chaiyawat, Parunya, Chutipongtanate, Somchai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456544/ https://www.ncbi.nlm.nih.gov/pubmed/36077137 http://dx.doi.org/10.3390/ijms23179741

Ejemplares similares

Expression profiling of DNA methyl transferase I (DNMT1) and efficacy of a DNA-hypomethylating agent (decitabine) in combination with chemotherapy in osteosarcoma
por: Chaiyawat, Parunya, et al.
Publicado: (2020)

IMPDH2 and HPRT expression and a prognostic significance in preoperative and postoperative patients with osteosarcoma
por: Chaiyawat, Parunya, et al.
Publicado: (2021)

Protein profiling of osteosarcoma tissue and soft callus unveils activation of the unfolded protein response pathway
por: Chaiyawat, Parunya, et al.
Publicado: (2019)

Exploring targeted therapy of osteosarcoma using proteomics data
por: Chaiyawat, Parunya, et al.
Publicado: (2017)

Genomics-Driven Precision Medicine in Pediatric Solid Tumors
por: Suthapot, Praewa, et al.
Publicado: (2023)

The Role of Proteomics and Phosphoproteomics in the Discovery of Therapeutic Targets and Biomarkers in Acquired EGFR-TKI-Resistant Non-Small Cell Lung Cancer
por: Moonmuang, Sutpirat, et al.
Publicado: (2023)

Expression patterns of class I histone deacetylases in osteosarcoma: a novel prognostic marker with potential therapeutic implications
por: Chaiyawat, Parunya, et al.
Publicado: (2018)

Activation Status of Receptor Tyrosine Kinases as an Early Predictive Marker of Response to Chemotherapy in Osteosarcoma
por: Chaiyawat, Parunya, et al.
Publicado: (2017)

Endoplasmic reticulum protein 29 (ERp29) as a novel prognostic marker and tumor suppressor in osteosarcoma
por: Chaiyawat, Parunya, et al.
Publicado: (2019)

Surgical outcomes of extracorporeal irradiation and re-implantation in extremities for high grade osteosarcoma: A retrospective cohort study and a systematic review of the literature
por: Pruksakorn, Dumnoensun, et al.
Publicado: (2018)

Circulating Long Non-Coding RNAs as Novel Potential Biomarkers for Osteogenic Sarcoma
por: Moonmuang, Sutpirat, et al.
Publicado: (2021)

Overexpression of KH-type splicing regulatory protein regulates proliferation, migration, and implantation ability of osteosarcoma
por: Pruksakorn, Dumnoensun, et al.
Publicado: (2016)

Osteosarcoma-Specific Genes as a Diagnostic Tool and Clinical Predictor of Tumor Progression
por: Sittiju, Pattaralawan, et al.
Publicado: (2022)

Prognostic score for life expectancy evaluation of lung cancer patients after bone metastasis
por: Pruksakorn, Dumnoensun, et al.
Publicado: (2017)

Clinical Implication of Circulating Tumor Cells Expressing Epithelial Mesenchymal Transition (EMT) and Cancer Stem Cell (CSC) Markers and Their Perspective in HCC: A Systematic Review
por: Orrapin, Santhasiri, et al.
Publicado: (2022)

Deciphering the Biology of Circulating Tumor Cells through Single-Cell RNA Sequencing: Implications for Precision Medicine in Cancer
por: Orrapin, Santhasiri, et al.
Publicado: (2023)

Safety and efficacy of intralesional steroid injection for aggressive fibromatosis
por: Pruksakorn, Dumnoensun, et al.
Publicado: (2017)

Phase II, multi-center, open-label, single-arm clinical trial evaluating the efficacy and safety of Mycophenolate Mofetil in patients with high-grade locally advanced or metastatic osteosarcoma (ESMMO): rationale and design of the ESMMO trial
por: Koonrungsesomboon, Nut, et al.
Publicado: (2020)

Mass Spectrometric Proteomics 2022
por: Iadarola, Paolo
Publicado: (2022)

Special Issue: Mass Spectrometric Proteomics
por: Iadarola, Paolo
Publicado: (2019)

Recurrent tibial intra-cortical osteosarcoma: a case report and review of the literature
por: Arpornchayanon, Olarn, et al.
Publicado: (2011)

Ankle ligament reconstruction after wide resection of the osteosarcoma of the distal fibula: a case report
por: Vaseenon, Tanawat, et al.
Publicado: (2017)

Descriptive epidemiology of soft tissue sarcomas and gastrointestinal stromal tumors in Thailand
por: Klangjorhor, Jeerawan, et al.
Publicado: (2022)

In-depth mass spectrometric mapping of the human vitreous proteome
por: Aretz, Sebastian, et al.
Publicado: (2013)

Defining the S-Glutathionylation Proteome by Biochemical and Mass Spectrometric Approaches
por: Li, Xiaolu, et al.
Publicado: (2022)

First study on the effect of transforming growth factor beta 1 and insulin-like growth factor 1 on the chondrogenesis of elephant articular chondrocytes in a scaffold-based 3D culture model
por: Tangyuenyong, Siriwan, et al.
Publicado: (2022)

Direct mass spectrometric characterization of disulfide linkages
por: Guan, Xiaoyan, et al.
Publicado: (2018)

Multiplex Biomarker Screening Assay for Urinary Extracellular Vesicles Study: A Targeted Label-Free Proteomic Approach
por: Chutipongtanate, Somchai, et al.
Publicado: (2018)

Mass spectrometric protein maps for biomarker discovery and clinical research
por: Liu, Yansheng, et al.
Publicado: (2013)

Advanced Mass Spectrometric Methods for the Rapid and Quantitative Characterization of Proteomes
por: Smith, Richard D.
Publicado: (2002)

Proteomics in Biomarker Discovery for Tuberculosis: Current Status and Future Perspectives
por: Guo, Jiubiao, et al.
Publicado: (2022)

Giant cell tumour of the middle phalanx of the middle finger
por: Adulkasem, Nath, et al.
Publicado: (2019)

Discovery of Biomarkers for Osteosarcoma by Proteomics Approaches
por: Suehara, Yoshiyuki, et al.
Publicado: (2012)

Immune Escape Mechanisms and Future Prospects for Immunotherapy in Neuroblastoma
por: Vanichapol, Thitinee, et al.
Publicado: (2018)

A proteome-wide immuno-mass spectrometric identification of serum autoantibodies
por: Music, Milena, et al.
Publicado: (2019)

Translational Proteomic Approach for Cholangiocarcinoma Biomarker Discovery, Validation, and Multiplex Assay Development: A Pilot Study
por: Watcharatanyatip, Kamolwan, et al.
Publicado: (2022)

Aberrant O-GlcNAcylated Proteins: New Perspectives in Breast and Colorectal Cancer
por: Chaiyawat, Parunya, et al.
Publicado: (2014)

Proteome-wide drug screening using mass spectrometric imaging of bead-arrays
por: Zhou, Ying, et al.
Publicado: (2016)

Correction to: A proteome-wide immuno-mass spectrometric identification of serum autoantibodies
por: Music, Milena, et al.
Publicado: (2019)

Mass spectrometric directed system for the continuous-flow synthesis and purification of diphenhydramine
por: Loren, Bradley P., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_d9mvlcltvo1jupshqi4fn1nq6r